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Abstract
Background: High Body Mass Index (BMI) and gestational weight gain (GWG) affect an increasing number of
pregnancies. The Institute of Medicine (IOM) has issued recommendations on the optimal GWG for women
according to their pre-pregnancy BMI (healthy, overweight or obese). It has been shown that pregnant
women rarely met the recommendations; however, it is unclear by how much. Previous studies also adjusted
the analyses for various women’s characteristics making their comparison challenging.
Methods: We analysed individual participant data (IPD) of healthy women with a singleton pregnancy and a
BMI of 18.5 kg/m2 or more from the control arms of 36 randomised trials (16 countries). Adjusted odds ratios
(aOR) and 95% confidence intervals (CI) were used to describe the association between GWG outside (above
or below) the IOM recommendations (2009) and risks of caesarean section, preterm birth, and large or small
for gestational age (LGA or SGA) infants. The association was examined overall, within the BMI categories and
by quartile of GWG departure from the IOM recommendations. We obtained aOR using mixed-effects logistic
regression, accounting for the within-study clustering and a priori identified characteristics.
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Results: Out of 4429 women (from 33 trials) meeting the inclusion criteria, two thirds gained weight outside
the IOM recommendations (1646 above; 1291 below). The median GWG outside the IOM recommendations
was 3.1 kg above and 2.7 kg below. In comparison to GWG within the IOM recommendations, GWG above
was associated with increased odds of caesarean section (aOR 1.50; 95%CI 1.25, 1.80), LGA (2.00; 1.58, 2.54),
and reduced odds of SGA (0.66; 0.50, 0.87); no significant effect on preterm birth was detected. The
relationship between GWG below the IOM recommendation and caesarean section or LGA was inconclusive;
however, the odds of preterm birth (1.94; 1.31, 2.28) and SGA (1.52; 1.18, 1.96) were increased.
Conclusions: Consistently with previous findings, adherence to the IOM recommendations seem to help achieve better
pregnancy outcomes. Nevertheless, even in the context of clinical trials, women find it difficult to adhere to them. Further
research should focus on identifying ways of achieving a healthier GWG as defined by the IOM recommendations.
Keywords: Gestational weight gain, Body mass index, Institute of Medicine, Individual participant data
Background
Gestational weight gain (GWG) is a natural response to ac-
commodate the growing fetus. Components of GWG in-
clude the body composition (fat, lean mass), the weight of
the fetus, placenta, and amniotic fluid [1]. Nonetheless, too
high or too low GWG contributes to short- and long-term
health complications [2–5], especially when a woman en-
ters pregnancy with a Body Mass Index (BMI) of 25 or
above [6–11]. The number of women entering pregnancy
with high BMI is increasing [12]. High weight gain in preg-
nancy occurs in both high-income [13–15] and low-income
countries [16, 17]. The US-based Institute of Medicine
(IOM), among others, has attempted to identify an optimal
amount of GWG [1, 2, 18–20] and has issued recommen-
dations to support healthcare providers advising women on
a healthy amount of weight gain in pregnancy [20]. Despite
their intention, only marginal improvement in the amount
of GWG in the US has been observed [21]. Outside the US,
the adoption of the recommendations vary [22]. For
example, the UK National Institute for Health and Care
Excellence (NICE) did not from endorse the IOM recom-
mendations, considering the evidence base insufficient to
guide clinical practice (retrospective population-based co-
horts) [22, 23].
Weight gain outside of the IOM recommendations is
widespread. In a recent meta-analysis of observational
studies with over a million pregnancies, two-thirds of eval-
uated women gained weight outside the IOM recommen-
dations [24]. As Individual Participant Data (IPD) from
those studies was not available, the degree of departure
from the recommendations is unknown. Although the
meta-analysis reaffirmed the association between GWG
outside the IOM recommendations and adverse preg-
nancy outcomes [4, 10, 17, 24–31], the findings were
limited by a lack of adjustment for potential confounders
(e.g. gestational age in the analysis for preterm birth),
inconsistency in outcome definitions (e.g. of preterm
birth). There was also considerable between-study hetero-
geneity; with a I2 value of below 30% in only one analysis
(caesarean section and gestational weight gain above the
IOM recommendation) in comparison to five analyses
where it was 70% or more [24]. Hence, the magnitude of
the association, commonly reported for any women whose
GWG is above or below the IOM recommendations, is
still uncertain. Our work therefore aimed to address these
gaps, using a repository of IPD from randomised trials
with details of relevant confounders and clear outcome
definitions, assembled by the International Weight man-
agement in Pregnancy (i-WIP) Collaborative group [32].
For women with GWG outside (above or below) the IOM
recommendations we estimated the odds of adverse preg-
nancy outcomes in comparison to those within (overall
and by BMI category), accounting for relevant con-
founders. We examined the degree to which women de-
parted from the IOM recommended ranges of weight
gain, and explored the change in the adjusted odds by the
degree of departure.
Methods
We included studies comprising of pregnant women
with a singleton fetus and maternal BMI (pre- or early
pregnancy) of 18.5 kg/m2 or more, that collected rele-
vant information on GWG. The relevant data were ob-
tained from the i-WIP IPD repository holding data from
36 randomised trials on lifestyle interventions in preg-
nancy [32, 33] from 16 countries across five geographical
regions (North and South America, Europe, Middle East,
and Australia) [34]. We only used data from participants
allocated to the control arms of those trials (standard
antenatal care as defined locally) thereby excluding any
potential variation due to intervention effects across the
studies. GWG was defined as the difference between the
last available antenatal weight (usually around delivery)
and the earliest weight measurement during pregnancy
or the pre-pregnancy weight if the former was not
available [32]. We evaluated both maternal and offspring
outcomes, namelycaesarean section (elective or emer-
gency), large for gestational age (LGA) or small for
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gestational age (SGA) infant, and preterm birth. The
outcomes were selected through a formal prioritisation
exercise and reflect clinical importance [35]. We harmo-
nised coding of the variables across datasets from all 36
trials [33], coding caesarean delivery as ‘any case of cae-
sarean delivery’ and ‘non-caesarean delivery’; LGA and
SGA as growth above the 90th centile, and below the
10th centile respectively; and preterm birth as birth earl-
ier than 37 weeks of gestation. For LGA and SGA we
first calculated the birth centiles using gestational age,
baby’s birth weight, maternal (pre- or early pregnancy)
weight, height and parity [36] before identifying infants
with growth above the 90th centile and below the 10th
centile.
The total GWG was categorised as above, within or
below the IOM recommendations (2009) according to the
woman’s initial (early or pre-pregnancy) BMI category as
defined by the WHO [37]. The recommended amount of
GWG is 11.5–16 kg, 7–11.5 kg, and 5–9 kg for women en-
tering pregnancy with healthy BMI (18.5–24.9 kg/m2) -
“normal BMI” in the WHO classification [37]; overweight
(25–29.9 kg/m2) and obese (≥ 30 kg/m2) respectively [20].
For women with a total GWG outside (above or below)
the IOM recommendations, we calculated the absolute
difference between the recorded value and the limit of the
recommended GWG and coded the direction of the dif-
ference (above or below the IOM recommendations). For
example, for a woman with healthy BMI (18.5–24.9 kg/
m2) where the recommended range is 11.5 to 16 kg, a total
GWG of 18 kg was coded as GWG of 2 kg above the IOM
recommendations. In the same BMI category, a total
GWG of 10 kg was coded as GWG of 1.5 kg below the
IOM recommendations.
We identified the potential confounders of the relation-
ship between the exposure (total GWG classified according
to the IOM recommendations) and the adverse pregnancy
outcomes through a literature review and based on a
consultation with the clinical experts (APB, ST). The con-
founders were prioritised from the clinical perspective, and
their availability assessed in the dataset (Additional file 1).
The number of covariates per model was limited by the
number of events (one covariate per 10 events) to prevent
overfitting [38]. Regression models with caesarean section
as of outcome were adjusted for occurrence of any dia-
betes-related event (defined as gestational diabetes or dia-
betes prior to pregnancy - yes/no), women’s age
(continuous), gestational age at delivery (continuous), parity
(nullipara/multipara), and smoking status (yes/no). Models
with LGA were adjusted for any diabetes-related events
(yes/no) and women’s age (continuous), and models with
SGA for smoking status (yes/no), women’s age (continuous)
and parity (nullipara/multipara). Due to a low number of
events, models for preterm birth could only be adjusted for
smoking status (yes/no). Moderators in the causal pathways
between the exposure and adverse pregnancy outcomes,
e.g. LGA for caesarean section, were not taken into account
in the adjusted models [38].
Statistical analysis
The characteristics were summarised as counts and per-
centages (categorical and dichotomous data), or as
means and standard deviations (SD) (continuous data).
Firstly, we examined the distribution of total GWG by
each kilogram outside (above or below) the IOM recom-
mendations and described it using the median, lower
[25] and upper (75) quartiles. The number of women
and events were tabulated according to the IOM
categories. We examined the relationship of GWG out-
side (above or below) the IOM recommendations and
adverse pregnancy outcomes using a one-stage IPD
meta-analytical framework.
In all models, we applied a mixed-effects logistic regres-
sion, accounting for clustering of participants within the
studies by including random effects for baseline differ-
ences on a study level [39]. Firstly, we computed the odds
ratio of adverse maternal and offspring outcomes for
women with GWG outside (above or below) versus within
the IOM recommendations, accounting for relevant
confounders. Secondly, we assessed the impact of the
magnitude of GWG outside (above or below) the IOM
recommendation on the odds of adverse pregnancy
outcomes. Due to the skewed distribution of the exposure,
we split it into quartiles and computed the odds of adverse
outcomes for each quartile of GWG outside (above or
below) the IOM recommendations in comparison to
within. The main models were performed including all
women, irrespective of their (pre- or early pregnancy)
BMI, but we accounted for these values in the analysis.
We subsequently assessed the effects by BMI category
(healthy BMI, overweight and obese). The relationship be-
tween the exposure and adverse outcomes was described
using odds ratio (OR) with respective 95% confidence
intervals (CI). There is no robust methodology to quantify
inter-study heterogeneity when using a one-stage random
effects model [40]. However, in cluster data analysis the I2
is very similar to the intraclass correlation coefficient
(ICC) [41] that we calculated for the adjusted models. We
did not attempt to impute any missing data. All analyses
were performed using Stata (version 14.1) with statistical
significance considered at the 5% level and no correction
for multiple testing.
A sensitivity analysis was performed for preterm birth
models to explore the impact of potential misclassification
of women who did not reach full term. An alternative in-
dicator of adherence to the IOM recommendations is by a
rate of GWG per week of pregnancy – for women with
healthy BMI 0.35–0.50 kg, overweight women 0.23–0.33
kg and obese women 0.17–0.27 kg [20, 42]. The values
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refer to rate of the GWG in the second and third trimester
and assume a linear progression of GWG [20]. Accord-
ingly, we calculated the rate of GWG by dividing the total
recorded GWG by the number of completed gestational
weeks in those trimesters.
Results
Individual records of 4429 women across 33 datasets
were available for analysis. The majority of women in
the available dataset were of Caucasian origin (91.3%),
over half were highly educated (55.8%) and in their first
pregnancy (51.3%). More than one-third (36.6%) had a
healthy BMI (pre- or early pregnancy), and over one-
third (35.3%) were obese (BMI ≥ 30 kg/m2) (Table 1).
The characteristics of women across the IOM categories
(above, within, and below) were broadly comparable,
with minor differences in the distribution by education
classes, smoking status, and presence of any diabetes-re-
lated events (Additional file 2).
Two-thirds of women gained weight outside the IOM
recommendations, 36.6% (1646/4429) were above, and
29% (1291/4429) were below. Nearly half of the women
with GWG above the IOM recommendations (46.9%,
772/1646), the upper limit by one to three kilograms
(Fig. 1). Over half of women (52.6%, 678/1291) with GWG
below the IOM recommendations were between one to
three kilograms below the IOM recommendations (Fig. 1).
Weight gain outside (above or below) the IOM recom-
mendations varied between the BMI categories (p < 0.001,
Pearson Chi2). Over half of overweight (641/1646; median
GWG outside the IOM recommendations of 2.9 kg) and
45% of obese women (695/1245; median GWG outside
the IOM recommendations of 3.6 kg) gained above the
IOM recommendations, compared to only 19% in the
healthy BMI category (310/1646, median 2.0 kg). GWG
was above the IOM recommendations by 1 kg in 20.6%
(64/310), 23.6% (151/641), and 11.7% (81/695) of women
with a healthy BMI, overweight and obese women respect-
ively (Fig. 1) (Additional file 3). More women with a
healthy BMI gained below the IOM recommendations
(40%, 649/1291; median − 3.4 kg) in comparison to
overweight (19%, 242/1291; median − 2.0 kg) and obese
women (25%, 400/1291; median − 2.4 kg). The weight gain
was below the IOM recommendations by 1 kg in 6.2% of
women with a healthy BMI (40/649), compared to 25.6%
(62/242) and 21.3% (85/400) in overweight and obese
women (Fig. 1).
Adverse pregnancy outcomes in women with GWG above
the IOM recommendations
Compared to women with GWG within the IOM rec-
ommendations, those who gained above had increased
odds of caesarean section (aOR 1.50, 95% CI 1.25, 1.80;
ICC 0.055) (Table 2). This increase was observed across
all baseline BMI categories – healthy BMI (aOR 1.58,
95% CI 1.09, 2.28; ICC 0.053), overweight (aOR 1.68,
95% CI 1.19, 2.35; ICC 0.071) and obese (aOR 1.44, 95%
CI 1.10, 1.89; ICC 0.027) (Table 2). The exploration of
the effect by quartile of GWG above the IOM recom-
mendations showed an increasing effect with greater
GWG departures (Fig. 2). We did not observe an associ-
ation of GWG above the IOM recommendations with
preterm birth (Table 2).
Compared to women with GWG within the IOM
recommendations, those who gained above the rec-
ommendations had increased odds of LGA (aOR 2.00,
Table 1 Characteristics of women in the control arms of
randomised trials included in the analyses
Characteristics Number of
studies
(women)
Mean (SD) or
Frequency (%)
Age (years) 32 (4415) 30.1 (5.1)
Height (cm) 31 (4422) 165.0 (7.0)
Weighta (kg) 33 (4429) 77.13 (18.4)
Body Mass Index (kg/m2) 31 (4429) 28.32 (6.37)
Body Mass Index categories 31 (4429)
Healthy BMI (BMI 18.5–24.99 kg/m2)b 1622 (36.6)
Overweight (BMI 25–29.99 kg/m2) 1245 (28.1)
Obese (BMI ≥ 30 kg/m2) 1562 (35.3)
Ethnic origin 24 (3536)
Caucasian 3232 (91.3)
Non-Caucasian 304 (8.7)
Education levelc 27 (3332)
Basic 453 (13.6)
Intermediate 1019 (30.6)
Higher 1860 (55.8)
Parity 30 (4317)
0 2113 (49.0)
1+ 2204 (51.0)
Current smoker 27 (3964) 693 (16.5)
Inactive before pregnancyd 25 (2760) 1377 (50.1)
Family history of diabetes 10 (1784) 455 (26.2)
Hypertension at baseline 20 (2154) 53 (2.5)
Any hypertensive event in pregnancye 24 (3502) 318 (9.1)
Any case of diabetes-related eventsf 31 (4422) 448 (10.1)
Gestational age at delivery (weeks) 31 (4419) 39.6 (1.6)
aEarly or pre pregnancy weight;
bequivalent of Body Mass Index (BMI) termed as normal in the World Health
Organization classification [20]
c’low’ (secondary education completed before A-levels), ‘medium’ (secondary
education to A-level equivalent) or ‘high’ (any further/higher education) for
details see Table 48 in Rogozinska et al. 2017 [33]
dDefined as no exercise or sedentary lifestyle prior to pregnancy for details see
Table 49 in Rogozinska et al. 2017 [33]
ePregnancy Induced Hypertension, high blood pressure, pre-eclampsia;
fGestational Diabetes Mellitus or pre-pregnancy Diabetes Mellitus;
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Fig. 1 Distribution of kilograms of gestational weight gain outside the Institute of Medicine recommendations (2009)
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95% CI 1.58, 2.54; ICC 0.115). The effect was ob-
served across all baseline BMI categories – healthy
BMI (aOR 1.68, 95% CI 1.10, 2.56; ICC 0.103),
overweight (aOR 1.83, 95% CI 1.20, 2.80; ICC 0.073)
and obese (aOR 2.75, 95% CI 1.80, 4.19; ICC 0.256)
(Table 2). Again the effect by quartile of GWG above
the IOM recommendations showed an increasing
effect with greater GWG departures (Fig. 2). There
was a 34% relative decrease in the odds of SGA over-
all (aOR 0.66, 95% CI 0.50, 0.87; ICC 0.078), with the
decrease observed in overweight (aOR 0.51, 95% CI
0.30, 0.87; ICC 0.172) and obese categories (aOR 0.65,
95% CI 0.42, 0.98; ICC not possible to estimate)
(Table 2), with an increasing effect observed again
Table 2 Gestational weight gain outside versus within the Institute of Medicine recommendations (2009) and the adverse
pregnancy outcomes
BMI category No. studies
(women)
OR (95% CI) No. studies
(women)
aOR (95%
CI)
No. studies
(women)
OR (95% CI) No. studies
(women)
aOR (95%
CI)
Gestational weight gain above the IOM recommendations
Caesarean sectiona Preterm birthb
All womene 30 (2727) 1.42 (1.20,
1.68)
24 (2700) 1.50 (1.25,
1.80)
30 (3126) 0.75 (0.50,
1.11)
26 (2769) 0.84 (0.54,
1.29)
Healthy BMIf (16
kg)
21 (949) 1.36 (0.96,
1.92)
21 (781) 1.58 (1.09,
2.28)
21 (971) 1.40 (0.70,
2.80)
19 (809) 1.73 (0.82,
3.65)
Overweight (11.5
kg)
29 (982) 1.43 (1.04,
1.98)
23 (877) 1.68 (1.19,
2.35)
29 (1000) 0.32 (0.15,
0.68)
25 (897) 0.40 (0.18,
0.86)
Obese (9 kg) 30 (1143) 1.29 (1.00,
1.68)
24 (1042) 1.44 (1.10,
1.89)
30 (1155) 0.81 (0.41,
1.59)
26 (1063) 0.89 (0.44,
1.80)
Large for Gestational Agec Small for Gestational Aged
All womene 31 (3138) 1.85 (1.47,
2.32)
30 (3123) 2.00 (1.58,
2.54)
30 (3123) 0.68 (0.52,
0.87)
25 (2754) 0.66 (0.50,
0.87)
Healthy BMI (16
kg)
21 (973) 1.77 (1.17,
2.70)
20 (967) 1.68 (1.10,
2.56)
21 (970) 0.89 (0.54,
1.44)
18 (803) 0.93 (0.56,
1.56)
Overweight (11.5
kg)
29 (1003) 1.68 (1.11,
2.53)
28 (998) 1.83 (1.20,
2.80)
29 (1000) 0.44 (0.27,
0.74)
24 (897) 0.51 (0.30,
0.87)
Obese (9 kg) 31 (1162) 2.53 (1.67,
3.83)
30 (1158) 2.75 (1.80,
4.19)
30 (1153) 0.71 (0.48,
1.05)
25 (1054) 0.65 (0.42,
0.98)
Gestational weight gain below the IOM recommendations
Caesarean sectiona Preterm birthb
All womene 30 (3074) 0.93 (0.76,
1.13)
24 (2395) 0.93 (0.75,
1.13)
30 (2769) 1.81 (1.26,
2.59)
26 (2486) 1.94 (1.31,
2.88)
Healthy BMI (11.5
kg)
21 (1285) 0.84 (0.60,
1.17)
21 (1082) 0.79 (0.55,
1.14)
21 (1309) 1.69 (0.95,
3.01)
19 (1131) 1.65 (0.86,
3.17)
Overweight (7 kg) 29 (590) 0.99 (0.65,
1.51)
23 (536) 0.83 (0.53,
1.31)
29 (601) 1.28 (0.62,
2.64)
25 (562) 1.58 (0.73,
3.43)
Obese (5 kg) 30 (852) 1.07 (0.80,
1.43)
24 (777) 1.10 (0.81,
1.51)
30 (859) 2.40 (1.28,
4.50)
26 (793) 2.39 (1.22,
4.68)
Large for Gestational Agec Small for Gestational Aged
All womene 31 (2783) 0.79 (0.59,
1.05)
30 (5880) 0.76 (0.57,
1.02)
30 (2762) 1.57 (1.24,
2.00)
25 (2446) 1.52 (1.18,
1.96)
Healthy BMI (11.5
kg)
21 (1312) 0.77 (0.50,
1.18)
20 (1294) 0.78 (0.51,
1.20)
21 (1304) 1.71 (1.16,
2.51)
18 (1113) 1.62 (1.07,
2.45)
Overweight (7 kg) 29 (604) 0.54 (0.28,
1.02)
28 (599) 0.53 (0.27,
1.02)
29 (601) 1.24 (0.74,
2.09)
24 (549) 1.24 (0.71,
2.16)
Obese (5 kg) 31 (467) 1.03 (0.62,
1.74)
30 (864) 0.98 (0.58,
1.66)
30 (857) 1.82 (1.24,
2.66)
25 (784) 1.81 (1.22,
2.71)
BMI Body Mass Index (kg/m2), OR Odds ratio, aOR Adjusted odds ratio, CI Confidence intervals, IOM Institute of Medicine
Models adjustments aAny event of diabetes, age, gestational age at delivery, parity, smoking; bSmoking; cAny event of diabetes, and woman’s age; dSmoking,
woman’s age, and parity; and BMI category; eAll relevant confounders and BMI category; statistically significant associations are in bold
Kilogram values in brackets indicate upper (weight gain above) or lower (weight gain below) value of the IOM recommendations (2009) for a given BMI
category [20]
fequivalent of BMI termed as normal in the World Health Organization classification [20]
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Fig. 2 Quartiles of gestational weight gain outside the Institute of Medicine recommendations (2009) and pregnancy complications
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with greater departures from the IOM recommenda-
tions (Fig. 2).
Adverse pregnancy outcomes in women with GWG below
the IOM recommendations
Compared to women with GWG within the IOM rec-
ommendations, for those who gained below the recom-
mendations, we did not observe a statistically significant
association with caesarean section (Table 2). The odds
of preterm birth were increased by 94% (aOR 1.94, 95%
CI 1.25, 1.80; ICC 0.149) with a significant increase ob-
served only in the obese category (aOR 2.39, 95% CI
1.22, 4.68; ICC 0.179) (Table 2). The exploration of the
effect by quartile of GWG below the IOM recom-
mendations showed an increasing effect with greater
departures (Fig. 2).
Compared to women with GWG within the IOM
recommendations, for those who gained below the recom-
mendations, we did not observe a statistically significant
association with LGA. The odds of SGA was increased by
52% (aOR 1.52, 95% CI 1.18, 1.96; ICC 0.078) (Table 2).
The effect for SGA was observed in healthy BMI (aOR
1.62, 95% CI 1.07, 2.45; ICC 0.141) and obese categories
(aOR 1.81, 95% CI 1.22, 2.71; ICC not possible to
estimate) (Table 2). We did not observe any clear trend in
the analysis by quartile of GWG below the IOM recom-
mendations (Fig. 2).
Sensitivity analysis
The analysis for preterm birth using the IOM classifica-
tion based on average weekly weight gain returned effect
estimates comparable to those obtained from the models
where women were classified based on their total GWG
(Additional file 4).
Discussion
In our dataset comprised of women from the control
arms (standard antenatal care) of 33 randomised trials
across 16 countries, two-thirds of women gained weight
outside the IOM recommendations. The degree of
GWG outside the recommendations varied depending
on the women’s pre-pregnancy BMI but was commonly
up to 3 kg irrespective of the direction (above: median
3.1 kg; below: median − 2.7 kg). GWG above the IOM
recommendations was most common in the obese sub-
group (median 3.6 kg) while women with healthy BMI
(median − 3.4 kg) were most likley to have GWG below
the IOM recommendations.
Weight gain outside the IOM recommendations was
associated with a change in the odds of adverse preg-
nancy outcomes. In comparison to weight gain within
the IOM recommendations, GWG above the recom-
mended amount was associated with 50% increased odds
of caesarean section and a two-fold odds of LGA.
Conversely, the odds of SGA were reduced by 36%, and
had no conclusive effect on preterm birth. For weight
gain below the IOM recommendations, however, the
odds of preterm birth was increased almost two-fold and
of SGA by 50%. The odds of LGA were decreased by
24%. There was no conclusive effect on the caesarean
section rate. The direction of the effects was consistent
across BMI category with the odds of an adverse preg-
nancy outcome being highed for the most extreme de-
partures from the IOM recommendations (5 kg or
more).
Our study was conducted using IPD from an inter-
national dataset of randomised trials and contributes to
the body of evidence on the relationship between
amount of gestational weight gain and pregnancy out-
comes [34]. The work avoids limitations of previous pri-
mary studies evaluating the non-adherence to the IOM
recommendations, which were mostly constrained to a
specific cohort of women (geographical or BMI limita-
tions), and secondary studies using aggregate study-level
data that do not allow for individual level adjustment
[10, 24, 28, 29, 43, 44]. Access to IPD in meta-analytical
approach allows adjusting for relevant confounders and
detecting participant rather than study-level associations
– a common limitation of study-level meta-analysis [45,
46]. The adjustment of the models in our analysis had
an effect on the magnitude of the pooled estimates. The
ICC, which we used to estimate an approximation of be-
tween-study heterogeneity, was between 3 and 26%, sug-
gesting reasonable consistency between the studies.
Finally, direct contact with trial authors facilitated data
integrity checks and allowed standardisation of defini-
tions for outcomes such as LGA, SGA and preterm
birth.
There are some limitations to our work. Even
though we used data from a cohort of women allo-
cated to control arms (standard antenatal care) of tri-
als targeting change in eating habits or activity level,
the participation in the trial on its own could affect
women’s behaviour and indirectly impact the amount
of gained weight [47, 48].
The ethnicity of the participants in the dataset (over
90% of Caucasian descent) potentially reduces the gener-
alisability of the findings onto other (non-Caucasian)
populations. However, there is no strong evidence that
the link between GWG and pregnancy complication dif-
fers across ethnicities [49], and the evidence base for the
IOM recommendations is itself limited as it mostly re-
fers to data from predominantly Caucasian women from
developed countries [1, 20].
The complex nature of the dataset with clustering of
records within the original trials creates particular chal-
lenges. For example, important covariates (e.g. fetal pres-
entation for caesarean section) were not always available
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in the individual trial datasets which resulted in the stat-
istical models not being adjusted for all relevant con-
founders. Furthermore, in the analyses, we only used
data from women allocated to control arms to simplify
the statistical models and improve the clinical interpret-
ability of their findings. This contributed to small sam-
ples of participants available for analysis of less frequent
outcomes (SGA and preterm birth) and within BMI
category (Additional file 5). Secondly, despite access to
patient-level records (IPD), some of the encountered
limitations were comparable to those reported for other
meta-analyses on the subject synthesis [24–26, 28, 29,
50]. For example, we could not use 23% of records in
the repository due to lack of initial or follow-up mea-
sures (for two trials, data was provided as total GWG
instead of individual weight measures). It was also not
always possible to use the measurement at the same
time point for the initial weight value (use of pre or early
pregnancy weight) and ensure the accuracy of its un-
biased recording (self-reported versus objectively mea-
sured). Moreover, the lack of measurements of weight at
the time of diagnosis did not permit exploration of the
relationship with outcomes such as pregnancy-induced
hypertension, pre-eclampsia or gestational diabetes.
We identified the potential confounders through a non-
systematic literature search and prospectively prioritised
them from the clinical perspective. The infant’s birth weight
was not considered as a potential confounder in any of the
models, as it is a component of GWG (examined exposure)
and outcomes such as SGA or LGA. In the analyses with
the caesarean section as a dependent variable, the infant’s
birth weight, especially high birth weight (LGA or macroso-
mia), was classified as a moderator of the exposure effect
(women’s gestational weight gain) on the outcome and
therefore not included in the model. The outcomes were
selected from a group of maternal and offspring outcomes
prioritised for their importance to women’s care in the con-
text of GWG management [35] and were concordant with
the outcomes evaluated by the IOM committee when
defining optimal GWG [20]. Finally, the findings of our
analyses may need to be treated with caution due to the
lack of correction for multiple testing.
As has been observed elsewhere [24], the majority of
women in our dataset gained outside the IOM recommenda-
tions. The IOM recommendations were commonly not met
by 0.1 up to 3 kg (above or below), and the direction and
magnitude of GWG outside the recommendations varied
across the BMI category. More overweight and obese
women gained weight above the IOM recommendations
than those who entered pregnancy with a healthy BMI. Preg-
nant women entering pregnancy overweight or obese are a
group of particular interest due to the risk of complications
being increased [11, 51]. The IOM recommendations incorp-
orate this additional risk by lowering the amount of GWG
for those BMI categories in comparison to women with
healthy pre-pregnancy BMI [20]. However, the literature
consistently shows that women from those BMI categories
frequently struggle to gain weight within the recommended
ranges [13, 27, 52] and carry over extra weight into subse-
quent pregnancies [53].
The direction of the pooled effects in the adjusted
analyses was mostly consistent with previous reports [24,
28, 29]. The exploratory analyses by quartile of weight gain
outside (above or below) the IOM recommendations
showed larger effects for the gain in the fourth quartile (5
kg or more), and were frequently inconclusive for the first
(0.1 to 1.4 kg) and second quartiles (1.4 to 3 kg). This may
be due to insufficient sample size in our dataset (especially
for preterm birth) or beacause of a weaker effect of smaller
amounts of weight gain outside the IOM recommendations
(0.1 to 1.4 kg). Nevertheless, a dose-response effect of
weight gain was clearly observed for caesarean section, LGA
and SGA and GWG above the IOM recommendations.
The prevention of excessive weight gain in pregnancy is
one of the WHO priorities for achieving a positive preg-
nancy experience [54]. Regular monitoring of weight gain
in pregnancy and provision of specific recommendations
are at present not part of standard antenatal care in the
United Kingdom [23] nor many other developed coun-
tries. Although the IOM recommendations are widely dis-
seminated and evaluated in clinical studies, the amount of
GWG they recommend was derived from a predominantly
Caucasian population, and their use in ethnically diverse
populations may not accurately describe the relationship
between low or high GWG and its adverse pregnancy out-
comes [55]. The distribution of GWG outside the IOM
recommendations needs to be explored in a large, ethnic-
ally diverse prospective population-based study to confirm
or refute our observations. Taking into account the rise of
caesarean section rates [56] and increased weight gain in
pregnancy [12], future studies should explore their rela-
tionship in more detail. Moreover, it is crucial to assemble
a dataset that will allow exploration of the relationship of
weight gain in pregnancy with other important outcomes
that could not be explored in our study, especially
gestational diabetes [57].
Conclusions
Consistently with previous findings, adherence to the IOM
recommendations seems to help achieve better pregnancy
outcomes. Even a moderate amount of GWG outside the
IOM recommendations adjusted for relevant characteristics
was associated with an increased risk of negative maternal
and offspring outcomes. Nevertheless, even in the context
of clinical trials, women find it challenging to meet the
IOM recommended amount of healthy GWG. Further re-
search should focus on identifying ways of achieving a
healthier GWG as defined by the IOM recommendations.
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